240 related articles for article (PubMed ID: 24625772)
1. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
[TBL] [Abstract][Full Text] [Related]
2. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
3. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer.
Du XL; Fang S; Vernon SW; El-Serag H; Shih YT; Davila J; Rasmus ML
Cancer; 2007 Aug; 110(3):660-9. PubMed ID: 17582625
[TBL] [Abstract][Full Text] [Related]
5. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer.
Hu CY; Chan W; Delclos GP; Du XL
Am J Clin Oncol; 2012 Jun; 35(3):228-36. PubMed ID: 21383605
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines.
Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB
Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931
[TBL] [Abstract][Full Text] [Related]
8. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
[TBL] [Abstract][Full Text] [Related]
10. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
Gross CP; McAvay GJ; Guo Z; Tinetti ME
Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973
[TBL] [Abstract][Full Text] [Related]
11. Racial/ethnic disparities in the adjuvant chemotherapy of locally advanced colon cancer patients.
Zhong X; Guo Z; Gao P; Song Y; Sun J; Chen X; Sun Y; Wang Z
J Surg Res; 2018 Aug; 228():27-34. PubMed ID: 29907221
[TBL] [Abstract][Full Text] [Related]
12. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
13. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
15. Estimating the adjuvant chemotherapy effect in elderly stage II and III colon cancer patients in an observational study.
Kim KY; Cha IH; Ahn JB; Kim NK; Rha SY; Chung HC; Roh JK; Shin SJ
J Surg Oncol; 2013 May; 107(6):613-8. PubMed ID: 23592499
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer.
Bradley CJ; Given CW; Dahman B; Fitzgerald TL
Arch Intern Med; 2008 Mar; 168(5):521-9. PubMed ID: 18332299
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J
Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068
[TBL] [Abstract][Full Text] [Related]
18. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer.
Cheung WY; Neville BA; Earle CC
Dis Colon Rectum; 2009 Jun; 52(6):1054-63; discussion 1064. PubMed ID: 19581846
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy for colon cancer].
Dahl O
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer.
Schrag D; Rifas-Shiman S; Saltz L; Bach PB; Begg CB
J Clin Oncol; 2002 Oct; 20(19):3999-4005. PubMed ID: 12351597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
